Tumor diameter, cavernous sinus invasion status, and the remission state and GH nadir levels at follow-up are key factors predicting the recovery or worsening of hyperprolactinemia and hypopituitarism after surgery. This evidence concerns the gene GH1 and hypopituitarism.